Patents by Inventor Nikhil Amin

Nikhil Amin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230146317
    Abstract: Methods for treating or preventing chronic spontaneous urticaria in a subject are provided. Methods comprising administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
    Type: Application
    Filed: July 25, 2022
    Publication date: May 11, 2023
    Inventors: Nikhil Amin, Elizabeth Laws, Leda Mannent, Allen Radin, Aleksandra Stjepanovic, Naimish Patel, Heribert Staudinger
  • Publication number: 20220169739
    Abstract: Methods for treating or preventing asthma in a pediatric subject are provided. Methods comprising administering to a pediatric subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
    Type: Application
    Filed: October 4, 2021
    Publication date: June 2, 2022
    Inventors: Christine Xu, Bolanle Akinlade, Nikhil Amin, Marcella Ruddy
  • Publication number: 20210380705
    Abstract: The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Application
    Filed: May 7, 2021
    Publication date: December 9, 2021
    Inventors: Nikhil Amin, Neil Graham, Gianluca Pirozzi, Ariel Teper
  • Publication number: 20210230265
    Abstract: Methods for treating or preventing COPD and associated conditions in a patient are provided. Methods comprising administering to a subject in need thereof a therapeutic composition comprising an interleukin-33 (IL-33) antagonist, such as an anti-IL-33 antibody or antigen-binding fragment thereof, are provided.
    Type: Application
    Filed: December 4, 2020
    Publication date: July 29, 2021
    Inventors: Raolat Abdulai, Alexander Boddy, Deborah Dukovic, Helene Goulaouic, Andreas Jessel, Xiaodong Luo, Heribert Staudinger, Ariel Teper, Marcella Ruddy, Nikhil Amin, Sivan Harel, Chad Nivens
  • Patent number: 11034768
    Abstract: The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: June 15, 2021
    Assignees: REGENERON PHARMACEUTICALS, INC.
    Inventors: Nikhil Amin, Neil Graham, Gianluca Pirozzi, Ariel Teper
  • Publication number: 20210032354
    Abstract: Methods for treating or preventing asthma (e.g., allergic asthma, asthma associated with allergic bronchopulmonary aspergillosis (ABPA), moderate-to-severe asthma, persistent asthma or the like) and associated conditions (e.g., ABPA, ABPA comorbid with asthma, ABPA comorbid with cystic fibrosis (CF), ABPA comorbid with asthma and CF) in a subject are provided. Methods comprising administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
    Type: Application
    Filed: July 15, 2020
    Publication date: February 4, 2021
    Inventors: Heribert Staudinger, Ariel Teper, Nikhil Amin, Sivan Harel, Neil Graham
  • Publication number: 20210000949
    Abstract: The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-33 (IL-33) antagonist, such as an anti-IL-33 antibody. The methods featured in the invention further comprise administering to a subject in need thereof a first therapeutic composition comprising an interleukin-33 (IL-33) antagonist, such as an anti-IL-33 antibody, and a second therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Application
    Filed: April 30, 2020
    Publication date: January 7, 2021
    Inventors: Helene Goulaouic, Andreas Jessel, Raolat Abdulai, Ariel Teper, Marcella Ruddy, Nikhil Amin, Sivan Harel, Weronika Szafran, John Huber, Joanna Pols
  • Publication number: 20200405731
    Abstract: A method for treating migraines is disclosed. The method utilizes a rapid drug delivery system which prevents deactivation or degradation of the active agent, including small molecules and peptides being administered to a patient in need of treatment. In particular, the drug delivery system is designed for inhalation for delivery of drugs to the pulmonary circulation in a rapid and therapeutically effective manner.
    Type: Application
    Filed: September 9, 2020
    Publication date: December 31, 2020
    Inventors: Joseph J. Guarneri, Marshall Grant, Chad C. Smutney, John J. Freeman, JR., Nikhil Amin, Kelly S. Kraft, Andrea Leone-Bay
  • Publication number: 20190321290
    Abstract: A prostaglandin composition and method for treating pulmonary arterial hypertension is disclose. The composition is based on diketopiperazine for pulmonary inhalation.
    Type: Application
    Filed: June 7, 2019
    Publication date: October 24, 2019
    Inventors: Joseph J. Guarneri, Nikhil Amin, Marshall L. Grant, John J. Freeman, Kelly S. Kraft
  • Publication number: 20190169299
    Abstract: The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Application
    Filed: October 29, 2018
    Publication date: June 6, 2019
    Inventors: Nikhil Amin, Neil Graham, Gianluca Pirozzi, Ariel Teper